Status:
COMPLETED
Renal Cysts and Primary Aldosteronism
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Helsinki University Central Hospital
Kuopio University Hospital
Conditions:
Primary Aldosteronism
Eligibility:
All Genders
18-80 years
Brief Summary
During routine subtyping of confirmed primary aldosteronism by adrenal vein sampling extra plasma samples are drawn from both renal veins and from inferior vena cava. Plasma renin concentration and re...
Detailed Description
Aim of the study is to evaluate the prevalence of renal cysts and their association with renin concentrationand acitivity in samples from renal veins and inferior vena cava (IVC) in patients who under...
Eligibility Criteria
Inclusion
- Confirmed primary aldosteronism according to Endocrine Society guidelines
- Adrenal vein sampling performed in Tampere University Hospital
- Informed consent
Exclusion
- \-
Key Trial Info
Start Date :
October 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT05435703
Start Date
October 7 2020
End Date
December 30 2021
Last Update
January 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland, 33521